| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.18 | 0.0008 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.086 | 0.001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.001 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |